XERS Operating Cash Flow (Statement)
Xeris Biopharma Holdings Inc · Operating Cash Flow (Statement)
XERS Operating Cash Flow (Statement)
Latest reported$56.61Mperiod ending
XERS TTM Cash from Operations (-$24.66M → $56.61M)
TTM operating cash flow (statement)
High-resolution chart · PNG
XERS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 56,608,000 | |
| 48,527,000 | |
| 28,626,000 | |
| 10,558,000 | |
| -16,179,000 | |
| -26,709,000 | |
| -36,981,000 | |
| -32,670,000 | |
| -38,975,000 | |
| -42,371,000 | |
| -48,208,000 | |
| -70,613,000 | |
| -73,757,000 | |
| -80,622,000 | |
| -102,891,000 | |
| -115,718,000 | |
| -120,575,000 | |
| -119,988,000 | |
| -95,535,000 | |
| -77,458,000 | |
| -71,832,000 | |
| -75,569,000 | |
| -80,558,000 | |
| -99,261,000 | |
| -112,859,000 | |
| -112,137,000 | |
| -104,346,000 | |
| -93,109,000 | |
| -78,443,000 | |
| -69,628,000 | |
| -56,279,000 | |
| -47,044,000 | |
| -36,704,000 | |
| -28,949,000 | |
| -24,663,000 |